Identifying patients with NTRK fusion cancer.
Solomon JP, Benayed R, Hechtman JF, Ladanyi M.
Ann Oncol. 2019 Nov 1;30(Suppl_8):viii16-viii22. doi: 10.1093/annonc/mdz384.
The landscape and therapeutic relevance of cancer-associated transcript fusions.
Yoshihara K, Wang Q, Torres-Garcia W, Zheng S, Vegesna R, Kim H, Verhaak RG.
Oncogene. 2015 Sep 10;34(37):4845-54. doi: 10.1038/onc.2014.406. Epub 2014 Dec 15.
Fusion-positive skin/adnexal carcinomas.
Agaimy A.
Genes Chromosomes Cancer. 2022 May;61(5):274-284. doi: 10.1002/gcc.23031. Epub 2022 Mar 7.
Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer.
Kohno T, Nakaoku T, Tsuta K, Tsuchihara K, Matsumoto S, Yoh K, Goto K.
Transl Lung Cancer Res. 2015 Apr;4(2):156-64. doi: 10.3978/j.issn.2218-6751.2014.11.11.
NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.
Solomon JP, Linkov I, Rosado A, Mullaney K, Rosen EY, Frosina D, Jungbluth AA, Zehir A, Benayed R, Drilon A, Hyman DM, Ladanyi M, Sireci AN, Hechtman JF.
Mod Pathol. 2020 Jan;33(1):38-46. doi: 10.1038/s41379-019-0324-7. Epub 2019 Aug 2.
The landscape of kinase fusions in cancer.
Stransky N, Cerami E, Schalm S, Kim JL, Lengauer C.
Nat Commun. 2014 Sep 10;5:4846. doi: 10.1038/ncomms5846.
How cells fuse.
Brukman NG, Uygur B, Podbilewicz B, Chernomordik LV.
J Cell Biol. 2019 May 6;218(5):1436-1451. doi: 10.1083/jcb.201901017. Epub 2019 Apr 1.
TumorFusions: an integrative resource for cancer-associated transcript fusions.
Hu X, Wang Q, Tang M, Barthel F, Amin S, Yoshihara K, Lang FM, Martinez-Ledesma E, Lee SH, Zheng S, Verhaak RGW.
Nucleic Acids Res. 2018 Jan 4;46(D1):D1144-D1149. doi: 10.1093/nar/gkx1018.
Recent advances in cancer fusion transcript detection.
Dorney R, Dhungel BP, Rasko JEJ, Hebbard L, Schmitz U.
Brief Bioinform. 2023 Jan 19;24(1):bbac519. doi: 10.1093/bib/bbac519.
Fusion Genes and RNAs in Cancer Development.
Taniue K, Akimitsu N.
Noncoding RNA. 2021 Feb 4;7(1):10. doi: 10.3390/ncrna7010010.
